Interest of Hypnosis When Setting up Non-invasive Ventilation in a Conscious Patient With COPD and/or Obesity With a BMI Greater Than 30, Suffering Fromacute Respiratory Distress in Adult Intensive Care
Launched by RENNES UNIVERSITY HOSPITAL · Jan 6, 2020
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of hypnosis to help patients with Chronic Obstructive Pulmonary Disease (COPD) and those who are obese (with a body mass index over 30) feel more comfortable while receiving non-invasive ventilation (NIV) in the intensive care unit. NIV is a treatment that helps patients with breathing difficulties, but it can be uncomfortable, especially for those with these conditions. The researchers hope that hypnosis can make the experience less stressful and improve how well patients can tolerate this therapy.
To be eligible for this study, participants must be adults aged 18 or older, admitted to the intensive care unit with acute respiratory failure due to COPD or obesity. They also need to be alert and able to provide consent. If someone joins the study, they can expect to receive support through hypnosis while undergoing NIV, which may help ease their discomfort. It's important to note that patients who are in critical condition or have certain mental health issues will not be included in the trial. This study is currently recruiting participants, and it aims to find a safer and more comfortable way to deliver this important treatment.
Gender
ALL
Eligibility criteria
- • Pre-inclusion criteria
- • Man or woman, aged 18 or over, admitted to medical intensive care
- • Glasgow score = 15
- • Patient with acute respiratory failure decompensating COPD and/or having obesity with a body mass index (BMI) greater than 30
- • Patient having given free, informed and written consent
- • Patient affiliated to a health insurance system
- Inclusion Criteria:
- • Glasgow score = 15
- • Need during use of non-invasive ventilation
- Exclusion Criteria:
- • Procedure to be carried out in extreme urgency (PaCO2 too high and leading to an immediate vital risk, and / or PaO2 too low) on medical decision
- • Confusional state making hypnosis impossible
- • Decompensated psychiatric illness
- • Patient entering with an NIV in place already installed in another department. The subject becomes included again at the end of the treatment with NIV if however he needs it again.
- • Patient already included in the study during previous non-invasive ventilation
- • Patient participating in research involving an interventional human person (category 1) on an analgesic / sedative medication
- • A person of full age subject to legal protection (safeguard of justice, curators, guardianship) or deprived of liberty
About Rennes University Hospital
Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, Bretagne, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials